Pulmonary toxicity of malaria prophylaxis.
作者信息
Davidson A C, Bateman C, Shovlin C, Marrinan M, Burton G H, Cameron I R
机构信息
Department of Medicine, United Medical School of Guy's Hospital, London.
出版信息
BMJ. 1988 Nov 12;297(6658):1240-1. doi: 10.1136/bmj.297.6658.1240.
Abstract
摘要
相似文献
1
Pulmonary toxicity of malaria prophylaxis.
BMJ. 1988 Nov 12;297(6658):1240-1. doi: 10.1136/bmj.297.6658.1240.
2
Maloprim-induced pulmonary eosinophilia.
Chest. 1993 Jan;103(1):305-6. doi: 10.1378/chest.103.1.305.
3
Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).使用疟涤平（乙胺嘧啶和氨苯砜）预防疟疾期间出现的粒细胞缺乏症。
Postgrad Med J. 1984 Aug;60(706):566-7. doi: 10.1136/pgmj.60.706.566.
4
Agranulocytosis associated with malaria prophylaxis with Maloprim.与使用疟涤平预防疟疾相关的粒细胞缺乏症。
Br Med J (Clin Res Ed). 1983 Apr 16;286(6373):1244-5. doi: 10.1136/bmj.286.6373.1244.
5
Maloprim for malaria prophylaxis.用于疟疾预防的疟涤平。
Med J Aust. 1985 Sep 30;143(7):319-20. doi: 10.5694/j.1326-5377.1985.tb123035.x.
6
Chemoprophylaxis of malaria in Africa.非洲疟疾的化学预防
Br Med J (Clin Res Ed). 1983 Feb 12;286(6364):562.
7
Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).乙胺嘧啶-磺胺多辛（Fansidar）诱发嗜酸性粒细胞性肺炎患者的磺胺多辛特异性淋巴细胞转化
Thorax. 1989 Apr;44(4):307-9. doi: 10.1136/thx.44.4.307.
8
Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.服用氨苯砜-乙胺嘧啶预防疟疾的健康男性发生急性非特异性上呼吸道感染的风险
Br Med J (Clin Res Ed). 1988 Mar 26;296(6626):893-5. doi: 10.1136/bmj.296.6626.893.
9
Severe dapsone syndrome due to weekly maloprim.因每周服用复方磺胺多辛导致的严重氨苯砜综合征。
Lancet. 1988 Mar 5;1(8584):531. doi: 10.1016/s0140-6736(88)91321-9.
10
Fixed drug eruptions to maloprim.对疟涤平的固定性药疹
Singapore Med J. 1988 Jun;29(3):300-2.
引用本文的文献
1
What obstetricians should be aware of: serious side effects of antibiotic toxoplasmosis treatment in pregnancy.产科医生应知晓：妊娠期抗生素弓形虫病治疗的严重副作用。
BMJ Case Rep. 2021 Mar 1;14(3):e240809. doi: 10.1136/bcr-2020-240809.
2
The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.再谈氨苯砜超敏反应综合征：一种具有显著肝肺表现的潜在致命性多系统疾病。
J Occup Med Toxicol. 2006 Jun 6;1:9. doi: 10.1186/1745-6673-1-9.
3
Eosinophilic pneumonia induced by dapsone.氨苯砜诱发的嗜酸性粒细胞性肺炎。
BMJ. 1998 Jul 18;317(7152):181. doi: 10.1136/bmj.317.7152.181.
4
Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.确定与化学预防抗疟药物相关的严重不良反应风险。
Bull World Health Organ. 1990;68(4):493-504.
本文引用的文献
1
Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).使用乙胺嘧啶-磺胺多辛（Fansidar）进行短期预防期间出现的异常肺部反应。
Br Med J (Clin Res Ed). 1984 Jun 23;288(6434):1876. doi: 10.1136/bmj.288.6434.1876.
2
Presumptive fatality due to pyrimethamine-sulfadoxine.推定因乙胺嘧啶-磺胺多辛致死。
Lancet. 1982 Dec 4;2(8310):1272. doi: 10.1016/s0140-6736(82)90121-0.
3
[Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].[使用乙胺嘧啶-磺胺多辛（Fansidar）预防疟疾期间的嗜酸性粒细胞性肺浸润]
Schweiz Med Wochenschr. 1985 Aug 24;115(34):1174-6.
4
Systemic reaction to pyrimethamine-sulfadoxine.对乙胺嘧啶-磺胺多辛的全身反应。
J Fam Pract. 1986 Apr;22(4):375-6.
5
Fansidar hypersensitivity pneumonitis.Fansidar诱发的过敏性肺炎。
Br J Dis Chest. 1987 Apr;81(2):194-6. doi: 10.1016/0007-0971(87)90140-9.
Zotero 插件